Connect your AI

Niagen Bioscience, Inc. Common Stock NAGE Q4 2024 Annual earnings

Reported March 4, 2025 · Before market open

Revenue$29.1MBeat by $2.4M Diluted EPS$0.03Beat by $0.01

Revenue estimate$26.8M

EPS estimate$0.02

Next report

Aug 5, 2026 (in a month)

Revenue estimate$31.7M

EPS estimate$0.01

Financials

Q4 2024

Income statement

Revenue$29.1M+37.4%

Gross profit$18.2M+40.7%

Operating income$7.1M+4,333%

Net income$7.2M—

EPS (diluted)$0.09+648,518,346,341,351,600%

Balance sheet

Cash & equivalents$44.7M+63.4%

Total debt$2.6M+591%

Total equity$46.1M+62.0%

Total assets$68.3M+24.2%

Cash flow

Operating cash flow$8.6M+1,222%

Valuation & ratios

Profitability

Gross margin61.8%+1.1pp

Operating margin7.8%+5.3pp

Net margin8.6%+6.1pp

Returns & leverage

Return on equity22.9%+16.0pp

Debt / equity0.1×0.0×

Current ratio3.6×+1.2×

Versus estimates

Revenue

Q1 2026$31.5MBeat by $444.0K Q4 2025$33.8MBeat by $2.1M Q3 2025$34.0MBeat by $2.9M Q2 2025$31.1MBeat by $354.8K Q1 2025$30.5MBeat by $3.4M

Q4 2024$29.1MBeat by $2.4M

Diluted EPS

Q1 2026$0.07Beat by $0.01 Q4 2025$0.03Beat by $0.01 Q3 2025$0.05Beat by $0.04 Q2 2025$0.04Beat by $0.02 Q1 2025$0.04Beat by $0.02

Q4 2024$0.03Beat by $0.01

Ask the moment Niagen Bioscience, Inc. Common Stock reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk

Questions, answered.

When did Niagen Bioscience, Inc. Common Stock report Q4 2024 earnings?: Niagen Bioscience, Inc. Common Stock (NAGE) reported Q4 2024 earnings on March 4, 2025 before market open.
What were Niagen Bioscience, Inc. Common Stock's Q4 2024 revenue and EPS?: Niagen Bioscience, Inc. Common Stock reported revenue of $29.1M and diluted EPS of $0.03 for Q4 2024.
Did Niagen Bioscience, Inc. Common Stock beat estimates in Q4 2024?: Revenue beat the consensus estimate of $26.8M by $2.4M. EPS beat the consensus estimate of $0.02 by $0.01.
Where can I find Niagen Bioscience, Inc. Common Stock's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001628280-25-009774) directly on SEC EDGAR. The filing index links above go to sec.gov.